1. Resources >>
  2. Companies directory >>
  3. PureTech Health
PureTech Health

PureTech Health

PureTech Health (LSE: PRTC) is an advanced biopharmaceutical company developing BIG medicines for dysfunctions of the Brain-Immune-Gut axis. The Company has gained deep insights into the connection between these systems and the resulting role in diseases that have proven resistant to established therapeutic approaches. By harnessing this emerging field of human biology, PureTech Health is developing new categories of medicines with the potential to have great impact on people with serious diseases. PureTech Health is advancing a rich pipeline of innovative therapies with an unbiased, non-binary, and capital efficient R&D model across its affiliates and its internal labs. PureTech’s affiliates include seven clinical-stage platforms, two products that have been filed with the FDA for review, and several other novel preclinical programs. The PureTech Health pipeline includes ground-breaking platforms and therapeutic candidates that were developed in collaboration with some of the world’s leading experts. PureTech’s internal research and development is centered on tissue-selective immunomodulation for the treatment of oncology, autoimmune, and CNS-related disorders, with a near-term focus on targeting newly-discovered, foundational immunosuppressive mechanisms in oncology and novel approaches that harness the lymphatic infrastructure. For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.
Industry
Biotechnology
Headquarters
Boston, Massachusetts, United States
Company size
100-200 employees
The most popular email templates:
PureTech Health’s email formatsPercentage
firstNameInitial_lastNameInitialj_d@puretechhealth.com78%
firstNameInitial_lastNamej_doe@puretechhealth.com41%
lastNameInitial.firstNamed.jane@puretechhealth.com62%
lastNamedoe@puretechhealth.com52%
firstNamelastNamejanedoe@puretechhealth.com74%
firstNameInitial.lastNamej.doe@puretechhealth.com40%

Our Integration Partners

+ 13 more